APA (7th ed.) Citation

Kaulen, L. D., Gumbinger, C., Hinz, F., Keßler, T., Winkler, F., Bendszus, M., . . . Wick, W. (2022). Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma. Neuro-oncology advances, 4(1), . https://doi.org/10.1093/noajnl/vdac051

Chicago Style (17th ed.) Citation

Kaulen, Leon D., Christoph Gumbinger, Felix Hinz, Tobias Keßler, Frank Winkler, Martin Bendszus, Felix Sahm, and Wolfgang Wick. "Intraventricular Immune Checkpoint Inhibition with Nivolumab in Relapsed Primary Central Nervous System Lymphoma." Neuro-oncology Advances 4, no. 1 (2022). https://doi.org/10.1093/noajnl/vdac051.

MLA (9th ed.) Citation

Kaulen, Leon D., et al. "Intraventricular Immune Checkpoint Inhibition with Nivolumab in Relapsed Primary Central Nervous System Lymphoma." Neuro-oncology Advances, vol. 4, no. 1, 2022, https://doi.org/10.1093/noajnl/vdac051.